Investors

The share

May 19th 2022, 1:44:18 pm +/- % Buy Sell Last High Low Volume
ENZY (Stockholm) SEK/share - 0.94% 4.82 4.84 4.84 4.89 4.78 12475

Share capital

At the end of 2021, the share capital of Enzymatica AB was SEK 5 972 977 SEK, distributed among 149 324 400 shares, each with a par value of SEK 0.04.

The Company has only one class of stock. Each share entitles the holder to one vote at Enzymatica’s general meeting of shareholders. Each shareholder who is entitled to vote may vote at the general meeting for the full number of shares that he or she owns and represents. Each share carries equal rights to a part of the Company’s assets and profit.

Dividend

The Board of Directors does not intend to propose any dividend until the Company generates a profit and a positive cash flow.

Ownership structure

The number of shareholders at year-end 2021 was 8420, a decrease with 12% compared to 2020.

Name

Number of shares

Percentage of capital and votes (%)

Mats Andersson, privately and through Abanico Invest AB

31 081 437

20,8%

Håkan Roos, through Roosgruppen AB

19 029 461

12,7%

Björn Algkvist through Fibonacci Asset Management

16 227 416

10,9%

Gudmundur Palmason, through Fortus hf company

7 142 496

4,8 %

Ágústa Gudmundsdottir, privately and through company

5 190 679

3,5%

Aktiebolaget Possessor

3 800 000

2,5%

Nordnet Pensionsförsäkring AB

3 798 272

2,5%

Avanza Pension Försäkring AB

3 213 875

2,2 %

Swedbank Försäkring

2 360 215

1,6%

Bengt Baron

2 324 408

1,6%

Holdings 10 largest shareholders

94 168 259

63,1%

Other

55 156 141

36,9 %

Total

149 324 400

100,0%

Euroclear 31 mars 2022

Analyses

During the year Enzymatica was analyzed by ABG Sundal Collier and Erik Penser Bank.

Rickard Anderkrans ABG Sundal Collier: rickard.anderkrans@abgsc.se

Johan Löchen, Penser: johan.lochen@penser.se